|
2025
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammato... |
|
|
P/S
|
Educational services, namely, providing a website featuring blogs and non-downloadable publicatio... |
|
|
P/S
|
Pharmaceutical products development relevant to Chimeric Degradation Activation Compounds; Scient... |
|
|
P/S
|
Providing secure online web messaging and telecommunications services, namely, electronic transmi... |
|
|
P/S
|
Telecommunication services, namely, providing secure online message sending services over Interne... |
|
|
Invention
|
Methods of treating multiple myeloma using bcl-2 inhibitor.
The present disclosure provides meth... |
|
|
Invention
|
Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor. ... |
|
2024
|
P/S
|
Médicaments pour la médecine humaine, préparations pharmaceutiques, préparations chimico-pharmace... |
|
|
P/S
|
Medicines for human medicine, pharmaceutical preparations,
chemico-pharmaceutical preparations, ... |
|
|
P/S
|
Charitable services, namely, providing grants to charitable organizations for programs that impro... |
|
|
Invention
|
Heterocyclic compounds, compositions thereof, and methods of treatment therewith. Provided herein... |
|
|
Invention
|
Anti-cea antibody drug conjugates and methods of use.
The present disclosure provides antibody d... |
|
|
Invention
|
Methods of treating myeloid malignancies using bcl-2 inhibitor.
The present disclosure provides ... |
|
|
Invention
|
Anti-pd1 antibodies and their use as therapeutics and diagnostics.
Provided are antibodies that ... |
|
|
P/S
|
Préparations pharmaceutiques; préparations chimico-pharmaceutiques; drogues à usage médical; prép... |
|
|
P/S
|
Pharmaceutical preparations; chemical-pharmaceutical
preparations; drugs for medical use; biolog... |
|
|
Invention
|
Anti-pd-1-based treatment before and after surgery. The disclosure relates to treatment of solid ... |
|
|
Invention
|
Solid forms comprising a b-raf kinase dimer inhibitor, methods of preparation, and uses therefor.... |
|
|
Invention
|
Ionizable lipids and lipid nanoparticles for rna delivery. Provided herein is novel ionizable cat... |
|
|
Invention
|
Stable high concentration arginine formulations containing pd-1 antibody and methods of use there... |
|
|
Invention
|
Substituted 6-(pyrimidin-4-yl)quinoline compounds as cyclin dependent kinase inhibitors. This dis... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious ... |
|
|
Invention
|
Stable high concentration sodium chloride formulations containing pd-1 antibody and methods of us... |
|
|
Invention
|
1-(1-oxo-1,2-dihydrophthalazin-6-yl)cycloalkyl-1-carboxamide derivatives as mta-cooperative inhib... |
|
|
Invention
|
Kat6 inhibitors.
Disclosed herein are compounds used as inhibitors of KAT6, or a pharmaceuticall... |
|
|
Invention
|
Kat6 inhibitors. Disclosed herein are compounds used as inhibitors of KAT6, or a pharmaceutically... |
|
|
Invention
|
4-((5-(3-(4-(pyridin-2-yl)cyclopentyl)-1 h-pyrazol-3-yl)amino)-benzenesulfonamide derivatives and... |
|
|
Invention
|
Muc1 and cd16a antibodies and methods of use.
The present disclosure provides for multi-specific... |
|
|
Invention
|
Circular rna and preparation methods thereof. Compositions and methods for efficiently constructi... |
|
|
Invention
|
Immune-related gene expression signatures and methods relating thereto. Among other things, the p... |
|
|
Invention
|
Bicyclic compounds as cdk inhibitors. Disclosed herein are bicyclic compound derivatives used as ... |
|
|
Invention
|
Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyraz... |
|
|
Invention
|
Treatment of esophageal cancer with anti-lag3, anti-pd-1 and chemotherapy. Described herein are m... |
|
|
Invention
|
Treatment of lung cancer with anti-pd-1 and chemotherapy. Provided is a treatment of lung cancer ... |
|
|
Invention
|
Bioactive conjugates, preparation method and use thereof. Provided herein are compounds comprisin... |
|
|
Invention
|
Quinoline derivatives and pharmarceutical compositions thereof for the treatment of disease. Disc... |
|
|
Invention
|
Bioactive conjugates, preparation method and use thereof. Compounds of formula (I) are provided, ... |
|
|
Invention
|
Bioactive conjugates, preparation method and use thereof. Compounds of formula (Ia) are provided,... |
|
|
Invention
|
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase lig... |
|
|
Invention
|
Antibody drug conjugates.
Antibody-drug conjugate compounds comprising a linker and methods of u... |
|
|
Invention
|
Solid forms of a tyk2 inhibitor, method of preparation, and use thereof.
Disclosed herein are a ... |
|
|
Invention
|
3,4-dihydroisoquinolin-1(2h)-ones derivatives as sting antagonists and the use thereof.
The disc... |
|
|
Invention
|
Benzofuran derivatives as sik inhibitors and use thereof. Provided are compounds of formula (I) a... |
|
|
Invention
|
Heterocyclic compounds.
Disclosed herein is a compound of Formula (I) having the following struc... |
|
|
Invention
|
Methods of synthesis of chiral 3,5-disubstituted morpholine compounds and intermediates useful th... |
|
|
Invention
|
Compounds for the degradation of egfr kinase. Disclosed herein are novel bifunctional compounds f... |
|
|
Invention
|
Compounds for the degradation of egfr kinase.
Disclosed herein are novel bifunctional compounds ... |
|
|
Invention
|
Methods of cancer treatment using anti-ox40 antibodies in combination with anti-pd1 antibodies. P... |
|
|
Invention
|
Isoquinolinone derivatives and 4h-quinolizinone derivatives and pharmarceutical compositions ther... |
|
|
Invention
|
Targeted pyrrolobenzodiazapine conjugates. Provided are compounds comprising pyrrolobenzodiazepin... |
|
|
Invention
|
Anti-cldn6 and anti-cd3 multispecific antibodies and methods of use.
The present disclosure prov... |
|
|
Invention
|
5-amino-6,8-dihydro-1h-furo[3,4-d]pyrrolo[3,2-b]pyridine-2-carboxamide derivatives as mta-coopera... |
|
|
Invention
|
5-amino-6, 8-dihydro-1h-furo [3, 4-d] pyrrolo [3, 2-b] pyridine-2-carboxamide derivatives as mta-... |
|
|
Invention
|
Bioactive conjugate, preparation method therefor and use thereof. The present disclosure provides... |
|
|
P/S
|
Medicines for human purposes, cachets for pharmaceutical
use, capsules for medicines, pharmaceut... |
|
|
Invention
|
Anti-b7h3 antibodies and methods of use. Provided are antibodies or antigen-binding fragments the... |
|
|
P/S
|
Providing consumer product information relating to pharmaceutical products in the nature of patie... |
|
|
P/S
|
pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious ... |
|
|
Invention
|
Solid forms of bcl-2 inhibitors, method of preparation, and use thereof.
The present invention r... |
|
2023
|
P/S
|
Educational services, namely providing a website featuring non-downloadable publications in the n... |
|
|
P/S
|
Downloadable software in the nature of a mobile application for learning medical and scientific r... |
|
|
P/S
|
Educational services, namely, providing a website featuring non-downloadable publications in the ... |
|
|
P/S
|
Education, namely, providing a website offering blogs and
non-downloadable publications in the n... |
|
|
P/S
|
Préparations pharmaceutiques; préparations chimio-pharmaceutiques; drogues à usage médical; prépa... |
|
2021
|
Invention
|
Methods of treating systemic lupus erythematosus using btk inhibitors.
Provided herein are metho... |
